Corrigendum to “Comparative Analysis of Biomarkers in Type 2 Diabetes Patients With and Without Comorbidities: Insights Into the Role of Hypertension and Cardiovascular Disease”

Corrigendum to “Comparative Analysis of Biomarkers in Type 2 Diabetes Patients With and Without Comorbidities: Insights Into the Role of Hypertension and Cardiovascular Disease”

Saved in:

Bibliographic Details
Format:	Article
Language:	English
Published:	SAGE Publishing 2025-02-01
Series:	Biomarker Insights
Online Access:	https://doi.org/10.1177/11772719251316045
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Comparative Analysis of Biomarkers in Type 2 Diabetes Patients With and Without Comorbidities: Insights Into the Role of Hypertension and Cardiovascular Disease
by: Symeon Savvopoulos, et al.
Published: (2024-02-01)

Rheumatic Diseases and Obesity: Adipocytokines as Potential Comorbidity Biomarkers for Cardiovascular Diseases
by: Rossana Scrivo, et al.
Published: (2013-01-01)

Hypertension, diabetes, and cardiovascular disease nexus: investigating the role of urbanization and lifestyle in Cabo Verde
by: Aaron Kobina Christian, et al.
Published: (2024-12-01)

Prevalence of Diabetes and Cardiovascular Comorbidity in the Canadian Community Health Survey 20022003
by: Frank Mo, et al.
Published: (2006-01-01)

Reverse Dipping of Blood Pressure in Patients of Hypertension with and without Type 2 Diabetes Mellitus
by: Kanwal Shahid, et al.
Published: (2024-12-01)

Cardiovascular Risk Biomarkers in Women with and Without Polycystic Ovary Syndrome
by: Manjula Nandakumar, et al.
Published: (2024-12-01)

Distinguishable Immunologic Characteristics of COVID-19 Patients with Comorbid Type 2 Diabetes Compared with Nondiabetic Individuals
by: Ruxing Zhao, et al.
Published: (2020-01-01)

Corrigendum: The role of fecal microbiota transplantation in type 2 diabetes mellitus treatment
by: Huimei Wang, et al.
Published: (2025-01-01)

The Humanistic and Economic Burden Associated with Anxiety and Depression among Adults with Comorbid Diabetes and Hypertension
by: Kimberly Wallace, et al.
Published: (2018-01-01)

Comparison Of ALT In Type 2 Diabetics with And Without Fatty Liver Disease
by: Kausar Malik, et al.
Published: (2023-06-01)

Trends in prescribing sodium‐glucose cotransporter 2 inhibitors for individuals with type 2 diabetes with and without cardiovascular‐renal disease in South Korea, 2015–2021
by: Kyoung Hwa Ha, et al.
Published: (2025-02-01)

Evaluation of Preptin and other Biomarkers in Coronary Artery Disease Patients with and without Diabetes Mellitus
by: Saja T. Yassen, et al.
Published: (2024-12-01)

Ferroptosis: mechanism and role in diabetes-related cardiovascular diseases
by: Ziyi Wang, et al.
Published: (2025-02-01)

Oxidative Stress and Its Biomarkers in Cardiovascular Diseases
by: Julija Valaitienė, et al.
Published: (2024-10-01)

Migraine-Asthma Comorbidity and Risk of Hypertensive Disorders of Pregnancy
by: Stefanie Czerwinski, et al.
Published: (2012-01-01)

GLP-1 Receptor Agonists and Cardiovascular Disease in Patients with Type 2 Diabetes
by: María Isabel del Olmo-Garcia, et al.
Published: (2018-01-01)

Main Comorbidities and Complications in Type 2 Diabetic Patients from Two Different Perspectives
by: Diana Serret López, et al.
Published: (2024-08-01)

Potentially Inappropriate Medications Use among Older Adults with Comorbid Diabetes and Hypertension in an Ambulatory Care Setting
by: Monira Alwhaibi
Published: (2022-01-01)

Role of phytochemicals in cardiovascular disease management: Insights into mechanisms, efficacy, and clinical application
by: Esther Ugo Alum
Published: (2025-02-01)

Characterization of diabetic kidney disease in 235 patients: clinical and pathological insights with or without concurrent non-diabetic kidney disease
by: Mengjie Jiang, et al.
Published: (2025-01-01)

In Women with Previous Pregnancy Hypertension, Levels of Cardiovascular Risk Biomarkers May Be Modulated by Haptoglobin Polymorphism
by: Andreia Matos, et al.
Published: (2014-01-01)

Biomarkers of Chronic Inflammatory State in Uremia and Cardiovascular Disease
by: Vincenzo Panichi, et al.
Published: (2012-01-01)

CKD patients comorbid with hypertension are associated with imbalanced gut microbiome
by: Pan Wang, et al.
Published: (2025-02-01)

Type 2 Diabetes and Cardiovascular Risk in Women 2016
by: Alexandra Kautzky-Willer, et al.
Published: (2017-01-01)

Estimation of Cardiovascular Risk in Patients with Type 2 Diabetes
by: Belkis Vicente Sánchez, et al.
Published: (2015-09-01)

Neurodegeneration in Patients with Type 2 Diabetes Mellitus without Diabetic Retinopathy
by: Elena Garcia-Martin, et al.
Published: (2019-01-01)

Clinical Characteristics and Prevalence of Comorbidities according to Metformin Use in Korean Patients with Type 2 Diabetes
by: Sang Ouk Chin, et al.
Published: (2020-01-01)

Hypertension and Diabetes: Entry Points for Prevention and Control of the Global Cardiovascular Epidemic
by: Shanthi Mendis, et al.
Published: (2013-01-01)

Integrated Approach for Biomarker Discovery and Mechanistic Insights into the Co-Pathogenesis of Type 2 Diabetes Mellitus and Non-Hodgkin Lymphoma
by: Zhu Y, et al.
Published: (2025-01-01)

Corrigendum: Obesity paradox in pulmonary hypertension secondary to chronic lung diseases
Published: (2025-01-01)

The Effects of Dipeptidyl Peptidase-4 Inhibitors on Cardiovascular Disease Risks in Type 2 Diabetes Mellitus
by: Pegah Yousefzadeh, et al.
Published: (2013-01-01)

Investigating the correlation of hip circumference to cardiovascular disease and type‐2 diabetes using Mendelian randomization
by: Hongtao Liu, et al.
Published: (2025-02-01)

Analysis of Changes in Retinal Thickness in Type 2 Diabetes without Diabetic Retinopathy
by: Jing Jiang, et al.
Published: (2018-01-01)

Prevalence and co-prevalence of comorbidities among patients with type 2 diabetes mellitus living in Puerto Rico
by: Enid J García-Rivera, et al.
Published: (2024-01-01)

Global Cardiovascular Risk Assessment in the Management of Primary Hypertension: The Role of the Kidney
by: Francesca Viazzi, et al.
Published: (2013-01-01)

Advanced point-of-care biomarker testing for the diagnosis of cardiovascular diseases
by: Wenjun Ming, et al.
Published: (2025-02-01)

Relationship between obesity indicators and hypertension–diabetes comorbidity among adults: a population study from Central China
by: Li Li, et al.
Published: (2022-07-01)

CARDIAC-STAR: prevalence of cardiovascular comorbidities in patients with HR + /HER2 − metastatic breast cancer
by: Susan Dent, et al.
Published: (2025-01-01)

Corrigendum to “Expression of Duodenal Iron Transporter Proteins in Diabetic Patients with and without Iron Deficiency Anemia”
by: Efrat Broide, et al.
Published: (2018-01-01)

Duchenne muscular dystrophy: recent insights in brain related comorbidities
by: Cyrille Vaillend, et al.
Published: (2025-02-01)